NSE: SRF | BSE: 503806

Expensive Performer

Download real time

2947.35 202.95 (7.40%)

High volume+gain today

NSE 11 Apr, 2025 3:31 PM (IST)

87,366.8

Market Cap

Market Runner Up

1.0

Beta 1Year

Average volatility

Capex

SRF sets up an agrochemical production facility in Gujarat, with a capex of Rs 190 crore See details

SRF Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SRF, BSE:503806 SRF Ltd.

Search Inside the pdf :

SRF Ltd.

24 Mar 2025

2947.35

7.40%

SRF LTD

Accumulate: SRF Ltd.

Geojit BNP Paribas

Number of FII/FPI investors decreased from 618 to 598 in Dec 2024 qtr

SRF Ltd.

28 Feb 2025

2947.35

7.40%

Chemical business to lead growth; Maintain Buy

Buy: SRF Ltd.

Target

Sharekhan

SRF’s fluorochemicals division shows strong demand with firm pricing. The company is investing Rs. 1,100 crore in less-polluting HFO (fourth generation) for FY28 launch.

SRF Ltd. is trading at high volume of 1.6M with price gain of 7.40.

SRF Ltd.

26 Feb 2025

2947.35

7.40%

Medium term outlook remains strong; re-iterate BUY

Buy: SRF Ltd.

Target

Emkay

We re-iterate BUY on SRF with revised SoTP-based TP of Rs3,250 (rollover to Mar-27E; up by 4.8%), as we believe the worst is behind for all businesses of SRF and, going forward, we should see gradual pick up in specialty chemicals driven by stabilization of existing products and incremental contribution from newer products (largely Active Ingredients).

SRF Ltd.'s price crossed above 50Day SMA today

SRF Ltd.

03 Feb 2025

2947.35

7.40%

SRF Ltd | Q3FY25 Result Update

Buy: SRF Ltd.

Target

Edelweiss

Recovery seen the chemicals business

SRF Ltd.'s price crossed above 50Day SMA today

SRF Ltd.

31 Jan 2025

2947.35

7.40%

Worst is behind; upgrade to BUY

Buy: SRF Ltd.

Emkay

We upgrade SRF to BUY from Add and raise our SoTP-based TP by over 19% to Rs3,100, as we believe i) the worst is behind for all of its businesses, ii) SRF is seeing gradual uptick in its specialty chemical business from existing products, and healthy contribution is expected from new AIs in FY26

SRF Ltd.'s price crossed above 30Day SMA today

SRF Ltd.

30 Jan 2025

2947.35

7.40%

Outlook improves for the Chemicals business

Buy: SRF Ltd.

Recommendation Target

Motilal Oswal

SRF posted a decent overall performance in 3QFY25. However, the Chemicals business and the Packaging Films business displayed material improvement during the quarter.

SRF Ltd. has an average target of 2905.50 from 9 brokers.

SRF Ltd.

25 Oct 2024

2947.35

7.40%

BP Equities Q2FY25 Result Update SRF Ltd

Results Update: SRF Ltd.

BP Wealth

SRF Ltd.'s price crossed above 50Day SMA today

SRF Ltd.

24 Oct 2024

2947.35

7.40%

Weak print; but order book visibility healthy for H2FY25

Hold: SRF Ltd.

Target

ICICI Securities Limited

SRF’s chemicals business is facing multiple headwinds from increased Chinese competition, weak demand from agro-chemical innovators, delay in new product commercialisation and drop in prices.

SRF Ltd.'s price crossed above 30Day SMA today

SRF Ltd.

24 Oct 2024

2947.35

7.40%

SRF: Q2FY25 Result Review

Hold: SRF Ltd.

IDBI Capital

SRF Ltd. has gained 25.49% in the last 6 Months

SRF Ltd.

23 Oct 2024

2947.35

7.40%

Weakness in the Chemicals business hampers performance

Neutral: SRF Ltd.

Target

Motilal Oswal

SRF posted weak performance in 2QFY25, with a material decline in operating profitability (EBIT down 22% YoY), due to the continuous weakness in the Chemicals business (EBIT dipped 29% YoY).

SRF Ltd.'s price crossed above 30Day SMA today

Is SRF Ltd. worth buying?

413 Votes:

Buy 74.82%

Sell 15.5%

Hold 9.69%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf